Xtx Topco LTD Dr Reddys Laboratories LTD Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$68.26 - $76.19 $498,639 - $556,567	7,305 New	7,305 $556,000
Q1 2023 May 12, 2023	BUY	$51.63 - $56.93 $303,584 - $334,748	5,880 New	5,880 $334,000
Q4 2021 Feb 11, 2022	SELL	$59.5 - $67.25 $185,521 - $209,685	-3,118 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$60.19 - $75.29 $187,672 - $234,754	3,118 New	3,118 $203,000

250

33.4M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.35B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.